Physician profile
Michael J Derrick
NPI 1790133734
$488.82
in general payments reported to CMS, 2019-2025
16 companies · $149 in 2025
The $149 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.37 · 2023: $191 · 2024: $134 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.18 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $105.17 | 2023-2024 | Accrufer |
| Novo Nordisk INC | $64.62 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $59.82 | 2023-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Cranial Technologies, INC | $39.73 | 2024-2025 | Doc Band |
| Dynavax Technologies Corporation | $33.63 | 2023 | Heplisav-B |
| Vertex Pharmaceuticals Incorporated | $24.97 | 2025 | |
| Kyowa Kirin, INC. | $20.16 | 2023 | Crysvita |
| Ironshore Pharmaceuticals INC. | $19.89 | 2024 | |
| Seqirus USA INC | $17.28 | 2025 | Flucelvax, Fluad |
| Ultragenyx Pharmaceutical INC. | $16.70 | 2023 | Crysvita |
| Janssen Pharmaceuticals, INC | $15.55 | 2024 | Spravato |
| Baxter Healthcare | $15.37 | 2019 | |
| Pfizer INC. | $14.34 | 2023 | |
| Circassia INC. | $14.15 | 2023 | Niox |
| Halozyme INC | $13.81 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.63 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Derrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.